(Q37387037)
Statements
1 reference
Ipilimumab: controversies in its development, utility and autoimmune adverse events (English)
1 reference
Jeffrey Weber
1 reference
6 February 2009
1 reference
1 reference
58
1 reference
5
1 reference
823-830
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference